Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions
Cancer Medicine · 2026-05 · 15 (5)
DOI: 10.1002/cam4.71794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 05.05.2026. Verfasst von Shuang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy, Mammaplasty, Immune Checkpoint Inhibitors. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, Guangzhou Municipal Nansha District Science and Technology Program Key Projects.
Abstract (Originalsprache)
Immunotherapy is transforming breast cancer management, but it also presents new challenges for surgical and reconstructive practice. This review summarizes current evidence on immune checkpoint inhibitors, perioperative safety, and immune‐related adverse events, highlighting their impact on surgical timing, postoperative recovery, and reconstructive outcomes. We also discuss interactions between implants and the tumor immune microenvironment and emphasize the need for individualized perioperative management. Finally, we identify key research gaps, including long‐term toxicity, real‐world surgical outcomes, and predictive biomarkers to guide reconstructive surgeons in integrating immunotherapy into multidisciplinary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Hepatobiliary Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, China.
- College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, Texas, USA.
- Department of Hepatobiliary Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
- State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, Chi…
- Department of General Surgery, Fifth Division, The First People's Hospital of Changde City, Changde, China.
ORCID-Profile: Shuang Li, Wenwu Cai, Yunjian Zhang
Förderung
- Special Project for Research and Development in Key areas of Guangdong Province
- Guangzhou Municipal Nansha District Science and Technology Program Key Projects
Zitieren
APA
Li, S., Wang, J., Liu, Y., Cai, W., Zhang, W., Li, S., & Zhang, Y. (2026). Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71794
Vancouver
Li S, Wang J, Liu Y, Cai W, Zhang W, Li S, et al. Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71794
BibTeX
@article{Li2026,
author = {Li, Shuang and Wang, Jianguo and Liu, Yingjie and Cai, Wenwu and Zhang, Weichang and Li, Shengyun and Zhang, Yunjian},
title = {Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/cam4.71794}
}
EUVIMED